Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From NuVasive, Inc.
Plus deals involving SK Biopharmaceuticals, Hikma and Proteovant, Day One/Sprint, Eyenovia/Formosa, Clinigen/CNX, Ikena/Pionyr and more.
Analysts from Piper Sandler and BTIG noted that the proposed merger between Globus Medical and NuVasive raises concerns about cultural fit, approach to commercialization and profitability, as well as anti-trust issues.
Already owner of about 60% of the troubled antibiotic firm, Innoviva agrees to pay $2.20 per share for all outstanding stock in Entasis. Roche, KaliVir partner on oncolytic virus therapies.
Longtime industry experts Kim Trautman, Steve Niedelman and Dennis Gucciardo spoke with Medtech Insight about interesting or insightful stakeholder comments on the US FDA’s proposed Quality Management System Regulation. Part one of two.
- Implantable Devices
- Monitoring Equipment & Devices
- Surgical Equipment & Devices
- Other Names / Subsidiaries
- Biotronic NeuroNetwork
- BNN Holdings Corp
- Ellipse Technologies, Inc.
- Impulse Monitoring, Inc.
- Mega Surgical
- NuVasive®, Inc
- NuVasive Clinical Services
- NuVasive Specialized Orthopedics, Inc.
- Simplify Medical, Inc.
- Vertera Spine
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.